Scompenso cardiaco, l’impatto dei nuovi trattamenti su outcome e QoL
Michele Senni
UOC Cardiologia – Dipartimento Cardiovascolare
ASST Papa Giovanni XXIII, Bergamo
Michele Senni
UOC Cardiologia – Dipartimento Cardiovascolare
ASST Papa Giovanni XXIII, Bergamo
Filippo Crea
Editor-in-chief
European Heart Journal
Stefano Urbinati
Presidente
Italian Federation of Cardiology
Stephan Achenbach
Cardiology
University of Erlangen
Il cardiologo è coinvolto in diversi aspetti della gestione della malattia di Fabry, dalla diagnosi differenziale alla stadiazione del coinvolgimento cardiaco, dalla scelta del trattamento al monitoraggio delle possibili interazioni. #RareDiseaseDay cardioinfo.it/in-pri…
Today is #RareDiseaseDay! There are over 6⃣0⃣0⃣0⃣ rare diseases 🌏 300 million people live with a rare disease accross the world Rare diseases currently affect 3.5% - 5.9% of the worldwide population👨👩👧👦 Learn more about what is a #raredisease 👉rarediseaseday.org/a… pic.twitter.com/frHq…
Several heart rhythm disorders can affect patients with Fabry disease, resulting in an increased risk of cardiovascular events. An insight by @mauripieroni72. @rarediseaseday #RareDiseaseDay #RareDiseaseDay2021 pic.twitter.com/JIXY…
🔎Amiloidosi cardiaca da transtiretina (#ATTRCM): malattia rara o sottodiagnosticata? 📽️ Guarda tutte le nostra interviste sul tema: bit.ly/3uG2Xcr #RareDiseaseDay #RareDiseaseDay2021
82yo 👩 ESRD (eGFR 16) and perm AF. CHADS-VASC 6. No previous stroke nor bleeding. Not eligible anymore for DOAC (nephrologist said!). Labile INR with VKA, regular venipuncture impossible. What now? Pls answer and re-tweet #cardiotwitter @SABOURETCardio @FeliceGragnano